Between 2000-2005, NSAIDs categorised as coxibs (celecoxib, rofecoxib, valdecoxib, etoricoxib) were the most preferred NSAIDs in managing osteoarthritis. The total NSAID market in India is ...

Etoricoxib was associated with small increases in the incidence of heart failure (absolute increase of 0.1%-0.4% depending on dose) and discontinuations due to edema (absolute increase 0.1%-1.1% ...

Etoricoxib is already available in some other parts of the world but it has struggled to reach the US market. That the current new drug application is considered approvable is seen as a positive ...

In primary care in England, 64,000 prescriptions for the highest etoricoxib dose (120 mg) were issued in 2007. Five studies with 880 participants were included in the review. Four followed ...

The results of a new study show that diclofenac, naproxen and etoricoxib significantly inhibit ovulation in women with mild musculoskeletal pain. Of the women receiving NSAIDs, only 6.3 percent ...

Oral etoricoxib is at least as effective as other drugs commonly used for pain relief after surgery. A Cochrane Systematic Review has confirmed the effectiveness of the drug, which.

In primary care in England, 64,000 prescriptions for the highest etoricoxib dose (120 mg) were issued in 2007. Five studies with 880 participants were included in the review. Four followed ...

Whether selective cyclo-oxygenase 2 inhibitors cause fewer gastrointestinal adverse events than traditional NSAIDs in patients who are also taking PPIs or cardioprotective aspirin remains unclear ...